Literature DB >> 22922237

Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States.

Neil Krishan Aggarwal1, Xiang Yang Zhang, Elina Stefanovics, Da Chun Chen, Mei Hong Xiu, Ke Xu, Robert A Rosenheck.   

Abstract

This article compares Positive and Negative Syndrome Scale (PANSS) data from Chinese and American inpatients with chronic schizophrenia to show how differences in item ratings may reflect cultural attitudes of raters. The Chinese sample (N = 504) came from Beijing Huilongguan Hospital. The American sample came from 268 PANSS assessments of Clinical Antipsychotic Trials of Intervention Effectiveness subjects hospitalized for 15 days or more to optimize equivalence of the samples. When controlling for age and sex, the Chinese sample scored significantly lower for total score by 25% (p < 0.0001), for the positive subscale by 35% (p < 0.0001), and on the general subscale by 32% (p < 0.0001) but not significantly different on the negative subscale score (+0.26%; p = 0.76). However, the Chinese sample scored 26% higher on the item on poor rapport (p < 0.0001), 10.2% higher on passive social withdrawal (p = 0.003), and most notably 46% higher on the item on lack of judgment and insight (p < 0.0001). These results remain broadly consistent across sex subgroup analyses. Differences seem to be best explained by both cultural differences in patient clinical presentations and varying American and Chinese cultural values affecting rater judgment.

Entities:  

Mesh:

Year:  2012        PMID: 22922237      PMCID: PMC3885177          DOI: 10.1097/NMD.0b013e318266bcaa

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  32 in total

1.  Exploring identity, culture, and suffering with a Kashmiri Sikh refugee.

Authors:  Neil Krishan Aggarwal
Journal:  Soc Sci Med       Date:  2007-07-25       Impact factor: 4.634

2.  Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms.

Authors:  M R Phillips; W Xiong; R W Wang; Y H Gao; X Q Wang; N P Zhang
Journal:  Acta Psychiatr Scand       Date:  1991-10       Impact factor: 6.392

3.  Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect.

Authors:  Y Igarashi; N Hayashi; M Yamashina; N Otsuka; N Kuroki; N Anzai; H Kazamatsuri
Journal:  Psychiatry Clin Neurosci       Date:  1998-10       Impact factor: 5.188

4.  Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific.

Authors:  Chien-Te Lee; Bernardo Jorge L Conde; Mahmud Mazlan; Taweesin Visanuyothin; Adrian Wang; Michael M C Wong; Daniel J Walker; Suraja M Roychowdhury; Huei Wang; Pierre V Tran
Journal:  J Clin Psychiatry       Date:  2002-07       Impact factor: 4.384

5.  Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone.

Authors:  Robert A Lasser; Cynthia A Bossie; Georges M Gharabawi; Martin Turner
Journal:  Eur Psychiatry       Date:  2004-06       Impact factor: 5.361

6.  A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

Authors:  Robert L Findling; Adelaide Robb; Margaretta Nyilas; Robert A Forbes; Na Jin; Svetlana Ivanova; Ronald Marcus; Robert D McQuade; Taro Iwamoto; William H Carson
Journal:  Am J Psychiatry       Date:  2008-09-02       Impact factor: 18.112

7.  Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone.

Authors:  Jim van Os; Cynthia A Bossie; Robert A Lasser
Journal:  Int Clin Psychopharmacol       Date:  2004-07       Impact factor: 1.659

8.  The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.

Authors:  L von Knorring; E Lindström
Journal:  Acta Psychiatr Scand       Date:  1992-12       Impact factor: 6.392

9.  Doctor-family-patient relationship: the Chinese paradigm of informed consent.

Authors:  Yali Cong
Journal:  J Med Philos       Date:  2004-04

10.  Gender differences in 542 Chinese inpatients with schizophrenia.

Authors:  Yi-Lang Tang; Charles F Gillespie; Michael P Epstein; Pei-Xian Mao; Feng Jiang; Qi Chen; Zhuo-Ji Cai; Philip B Mitchell
Journal:  Schizophr Res       Date:  2007-07-12       Impact factor: 4.939

View more
  3 in total

1.  Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.

Authors:  Benjamin Buck; Emily Scherer; Rachel Brian; Rui Wang; Weichen Wang; Andrew Campbell; Tanzeem Choudhury; Marta Hauser; John M Kane; Dror Ben-Zeev
Journal:  Schizophr Res       Date:  2019-03-30       Impact factor: 4.939

2.  Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China.

Authors:  Somaia Mohamed; Robert Rosenheck; Hongbo He; Ning Yuping
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

3.  A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups.

Authors:  Anzalee Khan; Christian Yavorsky; Stacy Liechti; Mark Opler; Brian Rothman; Guillermo DiClemente; Luka Lucic; Sofija Jovic; Toshiya Inada; Lawrence Yang
Journal:  BMC Psychol       Date:  2013-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.